Not investment advice. Educational platform. See Disclaimer.
NASDAQ: AARD
Aardvark Therapeutics, Inc. Common Stock
Healthcare | Biotechnology
$3.72-0.12 (-3.12%)as of 2026-07-14 20:08 UTC
Market Cap$80M
Volume107.6K
EPS (TTM)$-2.93
Aardvark Therapeutics, Inc. Common Stock (NASDAQ: AARD) is a $80M biotechnology company trading at $3.72 (−3.1% today). Figures from SEC EDGAR and market feeds; updated 2026-07-14 20:08 UTC.
52-Week Range
Low $3.35High $17.94
Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
What does Aardvark Therapeutics, Inc. Common Stock do?
Aardvark Therapeutics, Inc. Common Stock is a biotechnology company, listed on NASDAQ as AARD.
What is AARD's valuation?
AARD trades at $3.72, as of 2026-07-14.
When did AARD last file with the SEC?
Aardvark Therapeutics, Inc. Common Stock's most recent SEC filing on record is a DEF 14A filed 2026-07-10. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-07-14 20:08 UTC. This page is also available as JSON at /api/data?ticker=AARD and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for AARD and 3,500+ tickers.
